NM_000843.4:c.19G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000843.4(GRM6):​c.19G>A​(p.Ala7Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00762 in 1,189,594 control chromosomes in the GnomAD database, including 51 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0062 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0078 ( 45 hom. )

Consequence

GRM6
NM_000843.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6O:1

Conservation

PhyloP100: -1.52

Publications

3 publications found
Variant links:
Genes affected
GRM6 (HGNC:4598): (glutamate metabotropic receptor 6) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Mutations in this gene result in congenital stationary night blindness type 1B. [provided by RefSeq, May 2018]
GRM6 Gene-Disease associations (from GenCC):
  • congenital stationary night blindness 1B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • GRM6-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital stationary night blindness
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0041314065).
BP6
Variant 5-178994926-C-T is Benign according to our data. Variant chr5-178994926-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93440.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00617 (935/151488) while in subpopulation NFE AF = 0.00915 (619/67644). AF 95% confidence interval is 0.00855. There are 6 homozygotes in GnomAd4. There are 439 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000843.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
NM_000843.4
MANE Select
c.19G>Ap.Ala7Thr
missense
Exon 2 of 11NP_000834.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM6
ENST00000517717.3
TSL:5 MANE Select
c.19G>Ap.Ala7Thr
missense
Exon 2 of 11ENSP00000430767.1
GRM6
ENST00000231188.9
TSL:2
c.19G>Ap.Ala7Thr
missense
Exon 1 of 10ENSP00000231188.5
GRM6
ENST00000650031.1
c.19G>Ap.Ala7Thr
missense
Exon 3 of 12ENSP00000497110.1

Frequencies

GnomAD3 genomes
AF:
0.00619
AC:
937
AN:
151380
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00710
Gnomad ASJ
AF:
0.0200
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.00470
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00915
Gnomad OTH
AF:
0.00816
GnomAD2 exomes
AF:
0.0102
AC:
39
AN:
3836
AF XY:
0.0109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0127
Gnomad ASJ exome
AF:
0.0194
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.00862
GnomAD4 exome
AF:
0.00783
AC:
8125
AN:
1038106
Hom.:
45
Cov.:
32
AF XY:
0.00777
AC XY:
3835
AN XY:
493400
show subpopulations
African (AFR)
AF:
0.000672
AC:
14
AN:
20838
American (AMR)
AF:
0.00749
AC:
54
AN:
7214
Ashkenazi Jewish (ASJ)
AF:
0.0174
AC:
207
AN:
11928
East Asian (EAS)
AF:
0.0000466
AC:
1
AN:
21482
South Asian (SAS)
AF:
0.00366
AC:
82
AN:
22378
European-Finnish (FIN)
AF:
0.00400
AC:
74
AN:
18496
Middle Eastern (MID)
AF:
0.0136
AC:
36
AN:
2642
European-Non Finnish (NFE)
AF:
0.00825
AC:
7368
AN:
893322
Other (OTH)
AF:
0.00726
AC:
289
AN:
39806
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
421
843
1264
1686
2107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
320
640
960
1280
1600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00617
AC:
935
AN:
151488
Hom.:
6
Cov.:
33
AF XY:
0.00593
AC XY:
439
AN XY:
73992
show subpopulations
African (AFR)
AF:
0.00145
AC:
60
AN:
41456
American (AMR)
AF:
0.00709
AC:
108
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.0200
AC:
69
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5136
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4830
European-Finnish (FIN)
AF:
0.00470
AC:
49
AN:
10424
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.00915
AC:
619
AN:
67644
Other (OTH)
AF:
0.00807
AC:
17
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00164
Hom.:
0
Bravo
AF:
0.00605
ExAC
AF:
0.00156
AC:
25

ClinVar

ClinVar submissions as Germline

Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (5)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.54
CADD
Benign
0.27
DANN
Benign
0.97
DEOGEN2
Benign
0.089
T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.013
N
LIST_S2
Benign
0.33
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-0.78
T
MutationAssessor
Benign
0.0
N
PhyloP100
-1.5
PrimateAI
Pathogenic
0.81
D
PROVEAN
Benign
0.11
N
REVEL
Benign
0.16
Sift
Benign
0.60
T
Sift4G
Benign
0.66
T
Polyphen
0.0010
B
Vest4
0.070
MVP
0.33
MPC
1.2
ClinPred
0.0073
T
GERP RS
-1.6
PromoterAI
-0.014
Neutral
Varity_R
0.023
gMVP
0.38
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs62642053; hg19: chr5-178421927; COSMIC: COSV51432913; COSMIC: COSV51432913; API